Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies
Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies
复制标题
DOI：
10.1016/j.medcli.2014.05.027
复制
发表时间：
2015-08-21
期刊：
影响因子：
3.9
通讯作者：
Castells, Antoni
中科院分区：
文献类型：
--
作者：
Buron, Andrea;Grau, Jaume;Castells, Antoni
背景和目的：巴塞罗那结肠直肠癌筛查方案于2009年12月实施，涉及药店分发和收集筛查试验。本文的目的是根据欧盟建议的指标，描述该计划第一轮（2010-2011）的主要指标。材料和方法：巴塞罗那大肠癌筛查项目的目标人群为居住在医院诊所和del mar医院集水区的年龄在50-69岁的男性和女性。筛查包括两年一次的免疫化学粪便隐血检查，结肠镜检查作为确认程序。结果：目标人群为197,795人。参与率为43.6%，女性和60岁及以上人群的参与率更高。2.1%的合格人群表示已经接受过结直肠癌筛查。总体阳性率为6.2%，男性较高，各医疗保健领域差异较大。低、高风险腺瘤和浸润性癌症的检出率分别为9.1、21.7和3.1。48.2%的肿瘤为一期。结论：这些结果与其他9个项目的结果一致，符合欧洲标准。不过，已经确定了一些有待改进的领域。高参与率至少部分归因于测试的类型和社区药房的参与。(C) 2014 Elsevier Espana， S.L.U.版权所有
Background and objective: The Colorectal Cancer Screening Program of Barcelona was implemented in December 2009 and involves pharmacies for the distribution and collection of screening tests. The aim of this article is to describe the main indicators of the first round of the Program (2010-2011), based on the ones suggested by the European Union.Material and methods: The target population of the Colorectal Cancer Screening Program of Barcelona includes men and women aged 50-69 years who live in the catchment areas of Hospital Clinic and Hospital del Mar. Screening consists of biennial immunochemical fecal occult blood testing, with colonoscopy as confirmatory procedure.Results: Target population comprised 197,795 persons. Participation rate was 43.6%, was higher among women and among those aged 60 and older. 2.1% of the eligible population stated to have been already screened for colorectal cancer. Overall positivity rate was 6.2%, higher among men and with a broad variability among health care areas. The detection rates of low- and high-risk adenoma, and of invasive cancer were 9.1 parts per thousand, 21.7 parts per thousand and 3.1 parts per thousand, respectively. 48.2% of tumors were stage 1.Conclusions: These results are considered satisfactory and consistent with those obtained in other 9 programs and with European standards. Nevertheless, some areas for improvement have been identified. The high participation rate can be attributed, at least in part, to the type of test and to the involvement of community pharmacies. (C) 2014 Elsevier Espana, S.L.U. All rights reserved.